| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $15.0M | +102.4% |
| SG&A Expense | $12.6M | +361.6% |
| Operating Income | -$27.6M | -172.1% |
| Interest Expense | $775K | +9.7% |
| Net Income | -$27.0M | -148.1% |
| EPS (Basic) | -$1.56 | -92.6% |
| EPS (Diluted) | -$1.56 | -92.6% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.9M | +333.5% |
| Current Assets | $8.2M | +315.1% |
| Total Assets | $8.2M | +314.8% |
| Current Liabilities | $4.2M | +9.6% |
| Stockholders' Equity | $4.0M | +319.4% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.4M | -352.4% |
| Capital Expenditures | $2K | — |
| Financing Cash Flow | $17.6M | +303.4% |
| Free Cash Flow | -$11.4M | -352.5% |